Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Z A Massy

Showing results (11-20 of 84) with videos related to

Pageof 9
Sort By:
Journal of the American Society of Nephrology : JASN|July 1, 1996
Post-transplant hyperlipidemia: mechanisms and managementZ A Massy, B L Kasiske
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|December 6, 2001
Cyclooxygenase-2 and atherosclerosis: friend or foe?Z A Massy, S K Swan
Seminars in Nephrology|January 1, 1996
Pathogenesis of atherosclerosisZ A Massy, W F Keane
Current Opinion in Nephrology and Hypertension|March 1, 1996
Hyperlipidemia and its management in renal diseaseZ A Massy, B L Kasiske
Annals of Transplantation|May 31, 2002
Hyperhomocyst(e)inemia as a risk factor after renal transplantationD Ducloux, G Motte, Z A Massy
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|August 10, 2012
Lack of predictive value of FGF23 levels on pulse wave velocityL Desjardins, S Liabeuf, Z A Massy
Transplantation|March 8, 2000
Carotid atherosclerosis in renal transplant recipientsZ A Massy, T B Drüeke, H Kreis
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 1, 1994
Plasma mevalonate and its importance in nephrologyZ A Massy, C Guijarro, B L Kasiske
Transplantation|February 15, 1995
Effect of fenofibrates in heart transplant patientsZ A Massy, C Guijarro, B L Kasiske
Kidney International. Supplement|December 1, 1995
Clinical correlation between renal allograft failure and hyperlipidemiaC Guijarro, Z A Massy, B L Kasiske
Pageof 9

Showing results (11-20 of 84) with videos related to

Sort By:
Pageof 9
Journal of the American Society of Nephrology : JASN|July 1, 1996
Post-transplant hyperlipidemia: mechanisms and managementZ A Massy, B L Kasiske
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|December 6, 2001
Cyclooxygenase-2 and atherosclerosis: friend or foe?Z A Massy, S K Swan
Seminars in Nephrology|January 1, 1996
Pathogenesis of atherosclerosisZ A Massy, W F Keane
Current Opinion in Nephrology and Hypertension|March 1, 1996
Hyperlipidemia and its management in renal diseaseZ A Massy, B L Kasiske
Annals of Transplantation|May 31, 2002
Hyperhomocyst(e)inemia as a risk factor after renal transplantationD Ducloux, G Motte, Z A Massy
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|August 10, 2012
Lack of predictive value of FGF23 levels on pulse wave velocityL Desjardins, S Liabeuf, Z A Massy
Transplantation|March 8, 2000
Carotid atherosclerosis in renal transplant recipientsZ A Massy, T B Drüeke, H Kreis
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 1, 1994
Plasma mevalonate and its importance in nephrologyZ A Massy, C Guijarro, B L Kasiske
Transplantation|February 15, 1995
Effect of fenofibrates in heart transplant patientsZ A Massy, C Guijarro, B L Kasiske
Kidney International. Supplement|December 1, 1995
Clinical correlation between renal allograft failure and hyperlipidemiaC Guijarro, Z A Massy, B L Kasiske
Pageof 9